Reversible Cardiac Hypertrophy in Pulmonary Arterial Hypertension Treated With High-Dose Epoprostenol

Although current guidelines recommend the use of prostanoid infusion that includes epoprostenol for high-risk pulmonary arterial hypertension patients, epoprostenol has many adverse effects. We report a case of a heritable pulmonary arterial hypertension patient who had transient biventricular hyper...

Descripción completa

Detalles Bibliográficos
Autores principales: Izumi, Keiichi, Inami, Takumi, Takeuchi, Kaori, Kikuchi, Hanako, Goda, Ayumi, Hatano, Masaru, Kohno, Takashi, Sakata, Konomi, Shibahara, Junji, Soejima, Kyoko, Satoh, Toru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486866/
https://www.ncbi.nlm.nih.gov/pubmed/36148261
http://dx.doi.org/10.1016/j.cjco.2022.06.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486866/
https://www.ncbi.nlm.nih.gov/pubmed/36148261
http://dx.doi.org/10.1016/j.cjco.2022.06.009

Ejemplares similares